Cargando…
Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma
Glycine N-methyltransferase (GNMT) expression is vastly downregulated in hepatocellular carcinomas (HCC). High rates of GNMT knockout mice developed HCC, while overexpression of GNMT prevented aflatoxin-induced carcinogenicity and inhibited liver cancer cell proliferation. Therefore, in this study,...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881495/ https://www.ncbi.nlm.nih.gov/pubmed/27153064 http://dx.doi.org/10.3390/ijms17050669 |
_version_ | 1782433970707759104 |
---|---|
author | Kant, Rajni Yen, Chia-Hung Lu, Chung-Kuang Lin, Ying-Chi Li, Jih-Heng Chen, Yi-Ming Arthur |
author_facet | Kant, Rajni Yen, Chia-Hung Lu, Chung-Kuang Lin, Ying-Chi Li, Jih-Heng Chen, Yi-Ming Arthur |
author_sort | Kant, Rajni |
collection | PubMed |
description | Glycine N-methyltransferase (GNMT) expression is vastly downregulated in hepatocellular carcinomas (HCC). High rates of GNMT knockout mice developed HCC, while overexpression of GNMT prevented aflatoxin-induced carcinogenicity and inhibited liver cancer cell proliferation. Therefore, in this study, we aimed for the identification of a GNMT inducer for HCC therapy. We established a GNMT promoter-driven luciferase reporter assay as a drug screening platform. Screening of 324 pure compounds and 480 crude extracts from Chinese medicinal herbs resulted in the identification of Paeonia lactiflora Pall (PL) extract and the active component 1,2,3,4,6-penta-O-galloyl-β-d-glucopyranoside (PGG) as a GNMT inducer. Purified PL extract and PGG induced GNMT mRNA and protein expression in Huh7 human hepatoma cells and in xenograft tumors. PGG and PL extract had potent anti-HCC effects both in vitro and in vivo. Furthermore, PGG treatment induced apoptosis in Huh7 cells. Moreover, PGG treatment sensitized Huh7 cells to sorafenib treatment. Therefore, these results indicated that identifying a GNMT enhancer using the GNMT promoter-based assay might be a useful approach to find drugs for HCC. These data also suggested that PGG has therapeutic potential for the treatment of HCC. |
format | Online Article Text |
id | pubmed-4881495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-48814952016-05-27 Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma Kant, Rajni Yen, Chia-Hung Lu, Chung-Kuang Lin, Ying-Chi Li, Jih-Heng Chen, Yi-Ming Arthur Int J Mol Sci Article Glycine N-methyltransferase (GNMT) expression is vastly downregulated in hepatocellular carcinomas (HCC). High rates of GNMT knockout mice developed HCC, while overexpression of GNMT prevented aflatoxin-induced carcinogenicity and inhibited liver cancer cell proliferation. Therefore, in this study, we aimed for the identification of a GNMT inducer for HCC therapy. We established a GNMT promoter-driven luciferase reporter assay as a drug screening platform. Screening of 324 pure compounds and 480 crude extracts from Chinese medicinal herbs resulted in the identification of Paeonia lactiflora Pall (PL) extract and the active component 1,2,3,4,6-penta-O-galloyl-β-d-glucopyranoside (PGG) as a GNMT inducer. Purified PL extract and PGG induced GNMT mRNA and protein expression in Huh7 human hepatoma cells and in xenograft tumors. PGG and PL extract had potent anti-HCC effects both in vitro and in vivo. Furthermore, PGG treatment induced apoptosis in Huh7 cells. Moreover, PGG treatment sensitized Huh7 cells to sorafenib treatment. Therefore, these results indicated that identifying a GNMT enhancer using the GNMT promoter-based assay might be a useful approach to find drugs for HCC. These data also suggested that PGG has therapeutic potential for the treatment of HCC. MDPI 2016-05-04 /pmc/articles/PMC4881495/ /pubmed/27153064 http://dx.doi.org/10.3390/ijms17050669 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kant, Rajni Yen, Chia-Hung Lu, Chung-Kuang Lin, Ying-Chi Li, Jih-Heng Chen, Yi-Ming Arthur Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma |
title | Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma |
title_full | Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma |
title_fullStr | Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma |
title_full_unstemmed | Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma |
title_short | Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma |
title_sort | identification of 1,2,3,4,6-penta-o-galloyl-β-d-glucopyranoside as a glycine n-methyltransferase enhancer by high-throughput screening of natural products inhibits hepatocellular carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881495/ https://www.ncbi.nlm.nih.gov/pubmed/27153064 http://dx.doi.org/10.3390/ijms17050669 |
work_keys_str_mv | AT kantrajni identificationof12346pentaogalloylbdglucopyranosideasaglycinenmethyltransferaseenhancerbyhighthroughputscreeningofnaturalproductsinhibitshepatocellularcarcinoma AT yenchiahung identificationof12346pentaogalloylbdglucopyranosideasaglycinenmethyltransferaseenhancerbyhighthroughputscreeningofnaturalproductsinhibitshepatocellularcarcinoma AT luchungkuang identificationof12346pentaogalloylbdglucopyranosideasaglycinenmethyltransferaseenhancerbyhighthroughputscreeningofnaturalproductsinhibitshepatocellularcarcinoma AT linyingchi identificationof12346pentaogalloylbdglucopyranosideasaglycinenmethyltransferaseenhancerbyhighthroughputscreeningofnaturalproductsinhibitshepatocellularcarcinoma AT lijihheng identificationof12346pentaogalloylbdglucopyranosideasaglycinenmethyltransferaseenhancerbyhighthroughputscreeningofnaturalproductsinhibitshepatocellularcarcinoma AT chenyimingarthur identificationof12346pentaogalloylbdglucopyranosideasaglycinenmethyltransferaseenhancerbyhighthroughputscreeningofnaturalproductsinhibitshepatocellularcarcinoma |